Total Revenue

-2.4% (Q1 2025 vs Q1 2024)

Total Revenue declined by 2.4% primarily because lower sales in key segments—especially Consumer Domestic and Specialty Products—more than offset gains in Consumer International. This is consistent with previous period trends where reduced product volumes and adverse foreign exchange impacts challenged revenue growth ( " " ).

Consumer Domestic

-3.0% (Q1 2025 vs Q1 2024)

Consumer Domestic sales fell by 3% due to lower product volumes and the impact of strategic exits and divestitures that had begun affecting the revenue base in earlier periods. This decline reinforces established trends and reflects ongoing adjustments in the segment’s product mix ( " " ).

Consumer International

+2.7% (Q1 2025 vs Q1 2024)

An increase of 2.7% in Consumer International was driven by a strong uplift in product volumes (up 5.9%) and contributions from acquired product lines (+1.3%), which built on previous period momentum despite headwinds from currency fluctuations ( " " ).

Specialty Products

-12% (Q1 2025 vs Q1 2024)

Specialty Products experienced a 12% decline due to the continued impact of exiting product lines and divestitures that began in prior periods, compounded by competitive pressures and restructuring efforts in the division ( " " ).

Net Income

– (Q1 2025 level: $220.1 million; comparative YoY not specified)

While a direct YoY percentage for Net Income isn’t provided, Net Income at $220.1 million in Q1 2025 underscores strong profitability despite lower overall revenue, reflecting sustained cost efficiencies and favorable price/product mix improvements that were developing over previous periods ( " ).

Brand Performance and Market Share Gains

Q2 2024 discussion highlighted strong market share gains across power brands – for example, 5 out of 7 power brands growing share, notable performance in ARM & HAMMER laundry detergent, litter, THERABREATH mouthwash, and HERO acne care; consistent share gains even amid slowing category trends. " " "

Q1 2025 call reiterated robust brand performance with 9 out of 14 major brands gaining share, strong performance in categories like laundry, litter, mouthwash and acne care despite some challenges (e.g. gummy vitamins and BATISTE issues). " " " " "

Consistent performance in share gains across periods, although Q1 2025 introduces minor challenges in select categories, reinforcing overall strength despite a tougher macro backdrop.

Domestic Consumer Demand and Category Growth Deceleration

Q2 2024 commentary noted domestic consumption outpacing sales due to inventory adjustments, consumers’ price sensitivity, and a deceleration in growth across categories (e.g. laundry, mouthwash, and vitamins) with competitive pressures from private labels. " " "

Q1 2025 emphasized a further slowdown – with domestic consumer spending weakening (e.g. category growth around 1.5% or flat/negative, retail destocking impacting organic sales, and tariff uncertainty affecting demand). " " " " "

Worsening sentiment in current period with deeper category deceleration and increased impact of retail destocking and tariffs compared to Q2 2024.

Tariff Exposure Mitigation and Margin Pressure

In Q2 2024, the discussion was marked by a one-time benefit from a favorable tariff ruling that boosted gross margin (47.1%) and an acknowledgment of inflation-related cost pressures but with offsetting productivity gains; planning for trade and promotional spend was also mentioned. " " "

Q1 2025 focused on active measures to mitigate tariff exposure (with an expected 80% reduction) and detailed the ongoing margin pressures due to higher commodity and manufacturing costs; the gross margin contraction and embedded tariff impacts on EPS were stressed. " " " "

Shift in emphasis: from a one-time positive tariff effect in Q2 2024 to proactive tariff mitigation and managing sustained margin pressures in Q1 2025.

Capital Allocation and Portfolio Optimization

Q2 2024 discussion focused more on sustaining operations with increased CapEx (e.g. $76.6 million in 6-month CapEx and planned full-year investments) and a brief mention of annual portfolio evaluations, including challenges in the vitamin segment, though without major divestiture details. " " "

Q1 2025 significantly stressed capital allocation through a strong focus on M&A (with $6 billion firepower), share buybacks as a backup option, and deliberate portfolio optimization efforts (e.g. exiting FLAWLESS and Waterpik showerhead businesses, and scrutinizing the vitamins segment). " " " " "

Increased strategic rigor: Greater emphasis on M&A and active portfolio optimization in Q1 2025 compared to a more operational CapEx focus in Q2 2024.

Underperforming Vitamin Segment

Q2 2024 highlighted underperformance in the vitamin segment – gummy vitamins experienced a 10.9% decline, with the challenges attributed to internal delays in innovation, aggressive competition, shifts in consumer preferences, and private label gains. " " " "

Q1 2025 reported a steeper decline in the gummy vitamin business (19% drop in consumption), with the company unveiling initiatives such as reformulation, new product launches (e.g. PowerPlus, sugar-free variants), enhanced marketing, and plans to evaluate progress by July 2025. " " " " "

Persistent and deepening challenges in the vitamin segment, with new corrective strategies introduced in Q1 2025 that underscore ongoing difficulties compared to Q2 2024.

New Product Pipeline and Innovation

Q2 2024 called out an exceptional year for new product launches driving growth – with notable innovations such as ARM & HAMMER Deep Clean, Power Sheets, Hardball Clumping Litter, BATISTE dry shampoo variants, and THERABREATH Deep Clean Oral Rinse that reinforced a 60-40 premium-to-value product split. " " " "

Q1 2025 continued to underscore the importance of innovation, with new launches like BATISTE Light in dry shampoo, the mighty patch body in acne care, and advancements in the vitamins portfolio (e.g. PowerPlus), emphasizing that the pipeline remains a critical growth driver. " " "

Consistent and sustained focus on innovation across periods, with Q1 2025 reiterating the pipeline’s role in offsetting challenges and propelling growth.